905 filings
Page 4 of 46
8-K
TCRT
Alaunos Therapeutics Inc
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm
424B5
TCRT
Alaunos Therapeutics Inc
30 Nov 22
Prospectus supplement for primary offering
5:09pm
424B5
TCRT
Alaunos Therapeutics Inc
28 Nov 22
Prospectus supplement for primary offering
4:07pm
10-Q
2022 Q3
TCRT
Alaunos Therapeutics Inc
Quarterly report
14 Nov 22
7:31am
8-K
TCRT
Alaunos Therapeutics Inc
14 Nov 22
Alaunos Therapeutics Reports Third Quarter 2022 Financial Results
7:06am
8-K
TCRT
Alaunos Therapeutics Inc
7 Nov 22
Alaunos Therapeutics to Present Data Highlighting its hunTRâ„¢ TCR Discovery
8:10am
8-K
TCRT
Alaunos Therapeutics Inc
30 Sep 22
Other Events
8:00am
8-K
TCRT
Alaunos Therapeutics Inc
21 Sep 22
Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference
8:41am
4
Drew Deniger
19 Sep 22
Alaunos Therapeutics / Drew Deniger ownership change
4:30pm
4
Abhishek K Srivastava
19 Sep 22
Alaunos Therapeutics / Abhishek K Srivastava ownership change
4:30pm
4
Michael Wong
19 Sep 22
Alaunos Therapeutics / Michael Wong ownership change
4:30pm
4
Melinda Lackey
19 Sep 22
Alaunos Therapeutics / Melinda Lackey ownership change
4:30pm
EFFECT
TCRT
Alaunos Therapeutics Inc
8 Sep 22
Notice of effectiveness
12:15am
424B5
TCRT
Alaunos Therapeutics Inc
7 Sep 22
Prospectus supplement for primary offering
4:16pm
8-K
TCRT
Alaunos Therapeutics Inc
6 Sep 22
Alaunos Therapeutics Announces Early Clinical Data Showing Objective Clinical Response Using its TCR-T Cell Therapy
8:21am
CORRESP
TCRT
Alaunos Therapeutics Inc
2 Sep 22
Correspondence with SEC
12:00am
4
Kevin S. Sr. Boyle
1 Sep 22
Alaunos Therapeutics / Kevin S. Sr. Boyle ownership change
4:30pm
S-3/A
TCRT
Alaunos Therapeutics Inc
Shelf registration (amended)
31 Aug 22
4:43pm
8-K
TCRT
Alaunos Therapeutics Inc
24 Aug 22
Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference
4:45pm
UPLOAD
TCRT
Alaunos Therapeutics Inc
19 Aug 22
Letter from SEC
12:00am